This will be the first year that Obamacare's tax rules, including penalties, will go into effect. The NYT reports.» Read More
The Centers for Disease Control and Prevention confirmed the first case of Ebola in the United States at a Tuesday news conference.
Sarepta Therapeutics has enough Ebola treatments to handle about 100 patients, CEO Chris Garabedian says.
The Centers for Disease Control and Prevention on Tuesday confirmed the first case of Ebola has been diagnosed in the United States.
A few areas could be affected by news of the first U.S. case of Ebola, the "Fast Money" traders say.
The Ebola outbreak in West Africa is the deadliest on record and threatens to spread. What is this disease, and how do people get it?
Shares of pharmaceutical companies working on a drug to treat Ebola spiked after the CDC confirmed the first case diagnosed in the U.S.
Another day, another new wrist-wearable in gadgetland. But this one sounds … pretty compelling. Re/code explains.
Data released at the European Society of Medical Oncology meeting over the weekend showed much progress in fighting a number of cancers. Here's what investors need to know.
A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial.
Another large shareholder of Botox-maker Allergan is expressing concern over the company's corporate governance amid its fight to hold off hostile acquirer Valeant.
We must break from the unwritten code of "zero accountability" on women's health, says Yetnayet Asfaw.
Kadmon, the drug company founded by Sam Waksal of ImClone and Martha Stewart fame, is starting to look more and more like its founder's last company.
President Barack Obama said in a speech in the United Nations that more funding and awareness is needed, NBC News reports.
The World Bank on Thursday announced it would give another $170 million to help West African countries contain the spread of the Ebola virus.
Health-care stocks still have upside, Dan Chai of Iguana Healthcare Partners says.
Banned ImClone founder Sam Waksal's new biotech company, Kadmon, has plans to go public. The company aims to file with the SEC by the end of this year.
The Associated Press reports on the rising costs of living for middle-class Americans.
More insurers will sell Obamacare plans on HealthCare.gov for 2015 enrollment than did this year, heartening advocates of the health-care reform law.
US hospitals may be unprepared to safely dispose of the infectious waste generated by any Ebola virus disease patient to arrive unannounced.
The US government has been promising a crackdown on tax inversion deals for months. Yet the measures announced Monday may not be disincentive enough.
Get the best of CNBC in your inbox